0.04 | 0.04%
| Price and Volume | |
|---|---|
| Recent Price | 90.53 |
| 52 Week High | 97.09 |
| 52 Week Low | 69.40 |
| Avg. Daily Vol. (Mil) | 1.58 |
| Beta (3 year) | 0.62 |
| Share Related Items | |
| Mkt Cap (Mil) | 27,475.16 |
| Shares Out (Mil) | 303.49 |
| Float (Mil) | 304.06 |
| Dividend Information | |
| Yield % | 0.20 |
| Annual Dividend | 0.20 |
| Payout Ratio | 6.00 |
| Financial Strength | |
| Quick Ratio | 3.60 |
| Current Ratio | 4.40 |
| LT Debt/ Equity | 0.28 |
| Total Debt / Equity | 0.29 |
| Valuation Ratios | |
| Price Earnings | 27.90 |
| Price/Sales | 4.96 |
| Price/Book | 5.03 |
| Price/Cash Flow | 21.80 |
| Per Share Data | |
| Earnings | 3.24 |
| Sales | 18.25 |
| Book Value | 17.99 |
| Cash Flow | 4.15 |
| Business Summary | |
|---|---|
| Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential. | |
| General Information | |
| 2525 Dupont Drive
Irvine, CA 92612 |
|
| www.allergan.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 10000 | |
| CEO: David E.I. Pyott | |
| Short Interest | |
| Current Month (Mil) | 5.03 |
| Previous Month (Mil) | 3.93 |
| Short Interest Ratio (Days) | 3.10 |
| Management Effectiveness | |
| Return on Equity | 18.40 |
| Return on Assets | 11.60 |
| Return on Investments | 14.40 |
| Profitability | |
| Gross Margin | 88.60 |
| EBIT Margin | 26.60 |
| Profit Margin | 18.20 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.58
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet